These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29511967)

  • 1. Efficacy of a new delivery system based on solid lipid microparticles for the oral administration of the non-conventional antioxidant IAC on a diabetes mouse model.
    Canistro D; Vivarelli F; Cirillo S; Soleti A; Albertini B; Passerini N; Merizzi G; Paolini M
    J Endocrinol Invest; 2018 Oct; 41(10):1227-1236. PubMed ID: 29511967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.
    Novelli M; Bonamassa B; Masini M; Funel N; Canistro D; De Tata V; Martano M; Soleti A; Campani D; Paolini M; Masiello P
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Aug; 382(2):127-37. PubMed ID: 20512314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of microparticles for oral administration of the non-conventional radical scavenger IAC and testing in an inflammatory rat model.
    Passerini N; Albertini B; Sabatino MD; Corace G; Luppi B; Canistro D; Vivarelli F; Cirillo S; Soleti A; Merizzi G; Paolini M
    Int J Pharm; 2016 Oct; 512(1):126-136. PubMed ID: 27530293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of polysaccharides-based hydrogel microparticles as oral insulin delivery in streptozotocin-induced type 2 diabetic mice.
    Yang Y; Chen S; Liu Y; Huang Y; Cheong KL; Teng B; Liu W
    Biomed Pharmacother; 2021 Jan; 133():110941. PubMed ID: 33232923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
    Momoh MA; Kenechukwu FC; Attama AA
    Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the properties of Gongronema latifolium in phospholipon 90H based solid lipid microparticles (SLMs): an antidiabetic study.
    Chime SA; Onyishi IV; Ugwoke PU; Attama AA
    J Diet Suppl; 2014 Mar; 11(1):7-18. PubMed ID: 24409977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
    Kim BY; Jeong JH; Park K; Kim JD
    J Control Release; 2005 Feb; 102(3):525-38. PubMed ID: 15681076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery.
    D'Souza B; Bhowmik T; Uddin MN; Oettinger C; D'Souza M
    Drug Dev Ind Pharm; 2015; 41(8):1288-93. PubMed ID: 25156483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic, antihyperlipidaemic, and antioxidant activity of Syzygium densiflorum fruits in streptozotocin and nicotinamide-induced diabetic rats.
    Krishnasamy G; Muthusamy K; Chellappan DR; Subbiah N
    Pharm Biol; 2016 Sep; 54(9):1716-26. PubMed ID: 26704340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats.
    Nnamani PO; Attama AA; Ibezim EC; Adikwu MU
    Eur J Pharm Biopharm; 2010 Sep; 76(1):68-74. PubMed ID: 20554020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antidiabetic and antioxidant properties of Morinda lucida stem bark extract in streptozotocin intoxicated rats.
    Domekouo UL; Longo F; Tarkang PA; Tchinda AT; Tsabang N; Donfagsiteli NT; Tamze V; Kamtchouing P; Agbor GA
    Pak J Pharm Sci; 2016 May; 29(3):903-11. PubMed ID: 27166555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative and hypolipidemic efficacy of alcoholic seed extract of Swietenia macrophylla in streptozotocin diabetic rats.
    Kalpana K; Pugalendi KV
    J Basic Clin Physiol Pharmacol; 2011 Jun; 22(1-2):11-21. PubMed ID: 22865358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery.
    He P; Tang Z; Lin L; Deng M; Pang X; Zhuang X; Chen X
    Macromol Biosci; 2012 Apr; 12(4):547-56. PubMed ID: 22362708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms.
    Muntoni E; Anfossi L; Milla P; Marini E; Ferraris C; Capucchio MT; Colombino E; Segale L; Porta M; Battaglia L
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):691-698. PubMed ID: 33131992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenolic enriched extract of Cassia glauca Lamk, improves streptozotocin-induced type-1 diabetes linked with partial insulin resistance in rats.
    Veerapur VP; Pratap V; Thippeswamy BS; Marietta P; Bansal P; Kulkarni PV; Kulkarni VH
    J Ethnopharmacol; 2017 Feb; 198():489-498. PubMed ID: 28109916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-induced diabetic rats.
    Moree SS; Kavishankar GB; Rajesha J
    Phytomedicine; 2013 Feb; 20(3-4):237-45. PubMed ID: 23271000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihyperglycemic, antilipid peroxidation, and insulin secretory activities of Otostegia persica shoot extract in streptozotocin-induced diabetic rats and in vitro C187 pancreatic β-cells.
    Manzari-Tavakoli A; Pouraboli I; Yaghoobi MM; Mehrabani M; Mirtadzadini SM
    Pharm Biol; 2013 Feb; 51(2):253-9. PubMed ID: 23134106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.